ROS play a crucial role in regulating EMT in cancer, amplifying TGF‐β signaling, promoting EMT via SMAD‐dependent and SMAD‐independent routes, and activating the NF‐κB pathway, thereby contributing to EMT and immune evasion [87]. Here, TGFB1 is linked to cancer.